Side effects
Side effects as an overall problem
Side effects as an overall problem
Severity
Evaluations
Percentage
This item is relevant to you:
Severe
0
This item is relevant to you:
Moderate
5
This item is relevant to you:
Mild
13
This item is relevant to you:
None
21
Why patients stopped taking Mitragyna speciosa
Multiple reasons could be selected
Reason
Patients
Percentage
This item is relevant to you:
Change in health plan coverage
1
This item is relevant to you:
Other
1
This item is relevant to you:
Personal research
1
See
all
2 patients
who've
stopped using Mitragyna speciosa
Duration
Stopped using Mitragyna speciosa
Duration
Patients
Percentage
This item is relevant to you:
5 - 10 years
1
Adherence
Adherence
Evaluations
Percentage
This item is relevant to you:
Always
16
16 evaluations from 15 patients
This item is relevant to you:
Usually
17
17 evaluations from 12 patients
This item is relevant to you:
Sometimes
4
4 evaluations from 4 patients
This item is relevant to you:
Never
taken as prescribed
2
2 evaluations from 2 patients
Burden
Burden
Evaluations
Percentage
This item is relevant to you:
Very
hard to take
0
0 evaluations from 0 patients
This item is relevant to you:
Somewhat
hard to take
9
9 evaluations from 7 patients
This item is relevant to you:
A little
hard to take
12
12 evaluations from 10 patients
This item is relevant to you:
Not at all
hard to take
18
18 evaluations from 17 patients
Cost per month
Cost per month
Evaluations
Percentage
This item is relevant to you:
$200+
5
5 evaluations from 5 patients
This item is relevant to you:
$100-199
3
3 evaluations from 3 patients
This item is relevant to you:
$50-99
8
8 evaluations from 7 patients
This item is relevant to you:
$25-49
8
8 evaluations from 6 patients
This item is relevant to you:
< $25
1
1 evaluation from 1 patient
This item is relevant to you:
Not specified
14
14 evaluations from 11 patients
What people switch to and from
Patients
started
using
Mitragyna speciosa
after stopping:
Treatment
Patients
Percentage
This item is relevant to you:
Hydromorphone ER
(Exalgo )
1
Patients
stopped
using
Mitragyna speciosa
and
switched to:
Treatment
Patients
Percentage
This item is relevant to you:
Tramadol
(Ultram )
1
Last updated:
April 25, 2026